Catharine completed her PhD in Radiation Physics in 1998 at University College London. She then moved to Paris, France, where she worked at the Institut Gustave Roussy and then at Stanford University, California, USA. Catharine returned to the UK in 2001 and took up a post at the Royal Marsden. She led the IMRT QA for the first national head and neck IMRT trial and set up the UK IMRT credentialing programme. Catharine has worked in the field of IMRT for the last 10 years and has published widely in this area. She has lectured on IMRT on many national and international courses.
Catharine is currently a member of the ESTRO Physics Committee, acting as a consultant to IAEA and is a member of the National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad Workstream 4 - New technology, Physics and Quality Assurance). Previously, she was the chair of the ESTRO young members committee and was a member of the IPEM RTSIG IMRT Working Party, which published IPEM Report 96: Guidance for the Clinical Implementation of Intensity Modulated Radiation Therapy.
Catharine holds a joint post at the Royal Surrey Hospital and the National Physical Laboratory and is a member of the NCRI radiotherapy trials QA group.
Areas of interest
Catharine Clark's research interests are focused on the practical implementation and dosimetric verification of IMRT and rotational radiotherapy. She has also worked in the development of quality assurance in advanced radiotherapy trials and developed a credentialing program for IMRT trials in the UK. She recently led a national audit for the use of rotational therapy in the UK, which was awarded the highest scored physics proffered abstract at the ESTRO 2nd Forum Geneva April 2013, and has published 30 research papers and 90 conference abstracts on these topics.